Skye Bioscience Inc (SKYE)

[Vinpat]

I don't think they will attempt to uplist until the price is high enough to perhaps not even have to do a split. There's really no hurry now that they have cash. They'll be putting out news that will drive the price including clinical trial results and most likely a development deal. Keep in mind they will probably be able to qualify under the close price exceptions of either $2 or $3 per share and not have to be at $4.